The majority of PEComas have a loss of function (LOF) of TSC-1 or -2 genes (commonly TSC-2 LOF), leading to increased mTOR pathway activation. The gene discussed is MTOR; the disease is neoplasm with perivascular epithelioid cell differentiation.